Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia
Conditions
Interventions
Live, attenuated, dengue serotype 1, 2, 3, 4 virus
Placebo: Sodium chloride (NaCl) 0.9%
Locations
12
Indonesia
Denpasar, Bali, Indonesia
Bandung, West Java, Indonesia
Jakarta, Indonesia
Kuala Lumpur, Malaysia
Pulau Pinang, Malaysia
Cebu City, Philippines
Start Date
June 3, 2011
Primary Completion Date
August 1, 2014
Completion Date
November 21, 2017
Last Updated
March 21, 2022
NCT06579755
NCT04486638
NCT07007585
NCT06665035
NCT07040202
NCT06388785
Lead Sponsor
Sanofi Pasteur, a Sanofi Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions